Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Human COVID-19 Immunoglobulin (COVID-HIG) Therapy for COVID-19 Patients (NCT05173441) | Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd. | 2021-12-30 |
Track Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.